Literature DB >> 25343094

Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's disease.

Jianjun Gao1, Yoshinori Inagaki2, Yang Liu3.   

Abstract

Alzheimer's disease (AD) is a severe condition in aging countries. The currently used drugs including donepezil, rivastigmine, galantamine, and memantine are effective in managing the symptoms. However, they are hardly capable of preventing, halting, or reversing the disease. In the long history of development of traditional Chinese medicine, much experience has accumulated and is summarized in treatment of diseases that correspond to the concept of AD. In recent years, exploration of natural active ingredients from medicinal herbs for treatment of AD has attracted substantial attention. Some flavonoids have been revealed to have a variety of biological actions such as scavenging free radicals, inhibiting neuron apoptosis, and nurturing neuronal cells that constitute the basis for treatment of AD. In this article, we review recent research progress on flavonoids isolated from traditional Chinese medicine against AD and their underlying mechanisms.

Entities:  

Keywords:  Ginkgo flavonoids; apigenin; liquiritin; puerarin; soy isoflavones; total flavonoids of Baical Skullcap stem and leaf

Year:  2013        PMID: 25343094      PMCID: PMC4204571          DOI: 10.5582/irdr.2013.v2.1.3

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  65 in total

Review 1.  Alzheimer's disease.

Authors:  Jeffrey L Cummings
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

2.  Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells.

Authors:  Sam Sik Kang; Ji Yeon Lee; Yoo Keum Choi; Gap Seok Kim; Byung Hee Han
Journal:  Bioorg Med Chem Lett       Date:  2004-05-03       Impact factor: 2.823

3.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

Authors:  P L Le Bars; M M Katz; N Berman; T M Itil; A M Freedman; A F Schatzberg
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

4.  Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.

Authors:  S A Beresford; N S Weiss; L F Voigt; B McKnight
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

5.  Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid.

Authors:  N Sugihara; T Arakawa; M Ohnishi; K Furuno
Journal:  Free Radic Biol Med       Date:  1999-12       Impact factor: 7.376

Review 6.  Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

Authors:  Darrell W Brann; Krishnan Dhandapani; Chandramohan Wakade; Virendra B Mahesh; Mohammad M Khan
Journal:  Steroids       Date:  2007-02-21       Impact factor: 2.668

Review 7.  Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.

Authors:  V W Henderson
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

Review 8.  Review of drugs for Alzheimer's disease.

Authors:  Xiaoting Sun; Lan Jin; Peixue Ling
Journal:  Drug Discov Ther       Date:  2012-12

9.  Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin.

Authors:  B Jiang; J H Liu; Y M Bao; L J An
Journal:  Cell Biol Int       Date:  2003       Impact factor: 3.612

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  7 in total

Review 1.  A general description for Chinese medicine in treating premature ovarian failure.

Authors:  Jing Lin; Xue-Lian Li; Hui Song; Qian Li; Ming-Yan Wang; Xue-Min Qiu; Da-Jin Li; Ling Wang
Journal:  Chin J Integr Med       Date:  2017-03-07       Impact factor: 1.978

2.  Neuroprotective effect of the active components of three Chinese herbs on brain iron load in a mouse model of Alzheimer's disease.

Authors:  Xian-Hui Dong; Wei-Juan Gao; Wei-Na Kong; Hong-Lin Xie; Yan Peng; Tie-Mei Shao; Wen-Guo Yu; Xi-Qing Chai
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

3.  Doliroside A from Dolichos falcata Klein suppressing amyloid β-protein 42 fibrillogenesis: An insight at molecular level.

Authors:  Dongpu Li; Hongfei Yu; Qinxiong Lin; Yun Liu
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

4.  Inhibitory Effect of Lychee Seed Saponins on Apoptosis Induced by Aβ25-35 through Regulation of the Apoptotic and NF-κB Pathways in PC12 Cells.

Authors:  Xiuling Wang; Hong Zhang; Jian Liu; Rong Chen; Yong Tang; Haixia Chen; Li Gu; Mao Li; Shousong Cao; Dalian Qin; Jianming Wu
Journal:  Nutrients       Date:  2017-03-29       Impact factor: 5.717

Review 5.  Optimization of quercetin extraction method in Dendrobium officinale by response surface methodology.

Authors:  Yingpeng Zhu; Jiangliu Yu; Chunyan Jiao; Jinfeng Tong; Lei Zhang; Yan Chang; Weina Sun; Qing Jin; Yongping Cai
Journal:  Heliyon       Date:  2019-09-05

6.  Cryptotanshinone Alleviates Oxidative Stress and Reduces the Level of Abnormally Aggregated Protein in Caenorhabditis elegans AD Models.

Authors:  Wen-Bo Cui; Zong-Ping Zhang; Xue Bai; Shan-Shan Wang; Xiao-Han Chen; Xu Liu; Pan-Jie Su; De-Juan Zhi; Dong-Qing Fei; Zhan-Xin Zhang; Dong-Sheng Wang
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

7.  Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of Alzheimer's disease mice.

Authors:  Yu Zhang; Wei-Na Kong; Xi-Qing Chai
Journal:  Neural Regen Res       Date:  2018-04       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.